| Subgroup identification based on differential effect search—a recursive partitioning method for establishing response to treatment in patient subpopulations I Lipkovich, A Dmitrienko, J Denne, G Enas Statistics in medicine 30 (21), 2601-2621, 2011 | 344 | 2011 |
| Tutorial in biostatistics: data‐driven subgroup identification and analysis in clinical trials I Lipkovich, A Dmitrienko, R B D'Agostino Sr Statistics in medicine 36 (1), 136-196, 2017 | 285 | 2017 |
| Biplot and singular value decomposition macros for Excel© IA Lipkovich, EP Smith Journal of statistical software 7, 1-15, 2002 | 178 | 2002 |
| A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms BJ Kinon, I Lipkovich, SB Edwards, DH Adams, H Ascher-Svanum, ... Journal of clinical psychopharmacology 26 (2), 157-162, 2006 | 127 | 2006 |
| Strategies for identifying predictive biomarkers and subgroups with enhanced treatment effect in clinical trials using SIDES I Lipkovich, A Dmitrienko Journal of biopharmaceutical statistics 24 (1), 130-153, 2014 | 117 | 2014 |
| Propensity score estimation with missing values using a multiple imputation missingness pattern (MIMP) approach Y Qu, I Lipkovich Statistics in medicine 28 (9), 1402-1414, 2009 | 103 | 2009 |
| INFRISK: A computer simulation approach to risk management in infrastructure project finance transactions M Dailami, I Lipkovich, J Van Dyck Available at SSRN 620542, 1999 | 91 | 1999 |
| Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of … IA Lipkovich, W Deberdt, JG Csernansky, B Sabbe, RSE Keefe, ... BMC psychiatry 9, 1-12, 2009 | 90 | 2009 |
| Early predictors of substantial weight gain in bipolar patients treated with olanzapine I Lipkovich, L Citrome, R Perlis, W Deberdt, JP Houston, J Ahl, T Hardy Journal of clinical psychopharmacology 26 (3), 316-320, 2006 | 88 | 2006 |
| Weight-of-evidence (WOE): quantitative estimation of probability of impairment for individual and multiple lines of evidence EP Smith, I Lipkovich, K Ye Human and Ecological Risk Assessment 8 (7), 1585-1596, 2002 | 71 | 2002 |
| Delayed-start analysis: Mild Alzheimer's disease patients in solanezumab trials, 3.5 years H Liu-Seifert, E Siemers, KC Holdridge, SW Andersen, I Lipkovich, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 1 (2 …, 2015 | 61 | 2015 |
| Choosing estimands in clinical trials: putting the ICH E9 (R1) into practice B Ratitch, J Bell, C Mallinckrodt, JW Bartlett, N Goel, G Molenberghs, ... Therapeutic innovation & regulatory science 54, 324-341, 2020 | 57 | 2020 |
| Causal inference and estimands in clinical trials I Lipkovich, B Ratitch, CH Mallinckrodt Statistics in Biopharmaceutical Research 12 (1), 54-67, 2020 | 56 | 2020 |
| A multiple-imputation-based approach to sensitivity analyses and effectiveness assessments in longitudinal clinical trials BT Ayele, I Lipkovich, G Molenberghs, CH Mallinckrodt Journal of biopharmaceutical statistics 24 (2), 211-228, 2014 | 55 | 2014 |
| Aligning estimators with estimands in clinical trials: putting the ICH E9 (R1) guidelines into practice CH Mallinckrodt, J Bell, G Liu, B Ratitch, M O’kelly, I Lipkovich, P Singh, ... Therapeutic innovation & regulatory science 54, 353-364, 2020 | 52 | 2020 |
| General guidance on exploratory and confirmatory subgroup analysis in late-stage clinical trials A Dmitrienko, C Muysers, A Fritsch, I Lipkovich Journal of biopharmaceutical statistics 26 (1), 71-98, 2016 | 50 | 2016 |
| Combining analysis results from multiply imputed categorical data B Ratitch, I Lipkovich, M O’Kelly PharmaSUG 2013-Paper SP03 2013, 1-19, 2013 | 49 | 2013 |
| A structured approach to choosing estimands and estimators in longitudinal clinical trials CH Mallinckrodt, Q Lin, I Lipkovich, G Molenberghs Pharmaceutical Statistics 11 (6), 456-461, 2012 | 49 | 2012 |
| A macro for getting more out of your ROC curve J Lambert, I Lipkovich SAS Global forum, paper 231, 2008 | 48 | 2008 |
| Analyzing longitudinal clinical trial data: A practical guide C Mallinckrodt, I Lipkovich Chapman and Hall/CRC, 2016 | 47 | 2016 |
